INS and Parkinson disease: Our findings provide new insight into dopamine-mediated regulation of insulin secretion in primary rat islets, which also explains the cause of impaired insulin secretion and impaired glucose tolerance in Parkinson's disease patients treated with long-term dopaminergic drugs.